Publications
519
Citations
25,529
Est. group size
—
Recurring co-author estimate
Active years
47
Publishing since 1980
Debomoy K. Lahiri studies the biology of Alzheimer's disease and other neurodegenerative disorders, focusing on how small regulatory molecules called microRNAs control genes involved in the disease. The work combines cell and mouse models to investigate disease mechanisms and to test candidate treatments, including metal-binding compounds, immune-modulating drugs, and diabetes/obesity medications repurposed for brain protection.
After a peak around 2018-2019, annual output declined and has held at a steadier lower level in recent years, averaging about 7 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- MicroRNA-181 influences Alzheimer’s risk by regulating neprilysin and microtubule-associated tau pathways, offering a novel target
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease
Alzheimer s & Dementia · 2025
- MicroRNA‐153‐3p targets repressor element 1‐silencing transcription factor (REST) and neuronal differentiation: Implications for Alzheimer's disease
Alzheimer s & Dementia · 2025
- Novel properties of phenanthroline‐amine include binding to amyloid plaques and suppressing plaque growth in APP/PS1 mouse model of Alzheimer’s disease (AD)
Alzheimer s & Dementia · 2025
- Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?
Ageing Research Reviews · 2024
- Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
GeroScience · 2024
- Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) Cells
Biomolecules · 2024
- Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders
Brain Communications · 2024
- Optimization of the object recognition assay to test mouse cognition
Alzheimer s & Dementia · 2024
- Elevating brain GLP‐1 and GIP levels as a treatment strategy for neurodegenerative disorders
Alzheimer s & Dementia · 2024
- PAA, a novel metal chelator and metalloproteinase inhibitor significantly reduced amyloid plaque burden in an APP/tau mouse model of Alzheimer’s disease (AD)
Alzheimer s & Dementia · 2024
- Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer's disease.
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Mitigating chronic neuroinflammation in Alzheimer mice by novel immunomodulatory imide drugs (IMiDs) conserves neuroplasticity and cognitive function and also alleviates neurodegeneration‐behavioral impairments in TBI‐challenged mice
Alzheimer s & Dementia · 2023
- Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer’s Disease
Journal of Alzheimer s Disease · 2023
- Dietary sulfur amino acid restriction to prevent Alzheimer’s Disease
Alzheimer s & Dementia · 2023
- Alzheimer s & Dementia×31
- PMC×12
- Current Alzheimer Research×8
- Scientific Reports×7
- Molecular Psychiatry×6
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile